Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Using Thresholds in Noise to Identify Hidden Hearing Loss in Humans

Ridley, Courtney L.1,2; Kopun, Judy G.1; Neely, Stephen T.1; Gorga, Michael P.1; Rasetshwane, Daniel M.1

doi: 10.1097/AUD.0000000000000543
Research Articles

Objectives: Recent animal studies suggest that noise-induced synaptopathy may underlie a phenomenon that has been labeled hidden hearing loss (HHL). Noise exposure preferentially damages low spontaneous-rate auditory nerve fibers, which are involved in the processing of moderate- to high-level sounds and are more resistant to masking by background noise. Therefore, the effect of synaptopathy may be more evident in suprathreshold measures of auditory function, especially in the presence of background noise. The purpose of this study was to develop a statistical model for estimating HHL in humans using thresholds in noise as the outcome variable and measures that reflect the integrity of sites along the auditory pathway as explanatory variables. Our working hypothesis is that HHL is evident in the portion of the variance observed in thresholds in noise that is not dependent on thresholds in quiet, because this residual variance retains statistical dependence on other measures of suprathreshold function.

Design: Study participants included 13 adults with normal hearing (≤15 dB HL) and 20 adults with normal hearing at 1 kHz and sensorineural hearing loss at 4 kHz (>15 dB HL). Thresholds in noise were measured, and the residual of the correlation between thresholds in noise and thresholds in quiet, which we refer to as thresholds-in-noise residual, was used as the outcome measure for the model. Explanatory measures were as follows: (1) auditory brainstem response (ABR) waves I and V amplitudes; (2) electrocochleographic action potential and summating potential amplitudes; (3) distortion product otoacoustic emissions level; and (4) categorical loudness scaling. All measurements were made at two frequencies (1 and 4 kHz). ABR and electrocochleographic measurements were made at 80 and 100 dB peak equivalent sound pressure level, while wider ranges of levels were tested during distortion product otoacoustic emission and categorical loudness scaling measurements. A model relating the thresholds-in-noise residual and the explanatory measures was created using multiple linear regression analysis.

Results: Predictions of thresholds-in-noise residual using the model accounted for 61% (p < 0.01) and 48% (p < 0.01) of the variance in the measured thresholds-in-noise residual at 1 and 4 kHz, respectively.

Conclusions: Measures of thresholds in noise, the summating potential to action potential ratio, and ABR waves I and V amplitudes may be useful for the prediction of HHL in humans. With further development, our approach of quantifying HHL by the variance that remains in suprathreshold measures of auditory function after removing the variance due to thresholds in quiet, together with our statistical modeling, may provide a quantifiable and verifiable estimate of HHL in humans with normal hearing and with hearing loss. The current results are consistent with the view that inner hair cell and auditory nerve pathology may underlie suprathreshold auditory performance.

1Center for Hearing Research, Boys Town National Research Hospital, Omaha, Nebraska, USA

2Department of Speech, Language, and Hearing Sciences, University of Florida, Gainesville, Florida, USA.

Received April 28, 2017; accepted November 8, 2017.

This research was supported by the National Institutes of Health (NIH)–National Institute on Deafness and Other Communication Disorders grants T35 DC008757, R03 DC013982 and R01 DC016348 (to D.M.R.), R01 DC008318 (to S.T.N.), and P30 DC004662.

The authors have no conflicts of interest to disclose.

Address for correspondence: Daniel M. Rasetshwane, Center for Hearing Research, Boys Town National Research Hospital, 555 North 30th Street, Omaha, NE 68131, USA. Email: daniel.rasetshwane@boystown.org

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.